Variable | Total patients | Percentage |
---|---|---|
Initial treatment | ||
 Chemotherapy | 100 | 50 |
 Radiotherapya | 13 | 6.5 |
 Surgery alone | 16 | 8 |
 Chemotherapy + Radiotherapy | 68 | 34 |
 Rituximab alone | 2 | 1 |
 Refused / No show | 1 | 0.5 |
Type of chemotherapy | ||
 ABVDb | 147 | 73.5 |
 ABVD/ABV with COPP like | 3 | 1.5 |
 COPPb | 5 | 2.5 |
 R-CHOPc | 11 | 5.5 |
 Othersd | 6 | 3 |
Number of initial chemo cycle | ||
 2 cycles a | 31 | 15.5 |
 3 cycles | 11 | 5.5 |
 4 cycles | 64 | 32 |
 6 cycles a | 53 | 26.5 |
 8 cycles | 11 | 5.5 |
Response after initial treatment | ||
 CR | 164 | 82 |
 PR | 11 | 5.5 |
 PDb | 21 | 11.5 |
 On treatment | 1 | 0.5 |
Tissue confirmation at Rx failure | ||
 Type of first event | 200 | 100 |
  No event | 124 | 62 |
  Persistent disease | 12 | 6 |
  Progressive disease | 21 | 10.5 |
  Relapsed disease | 36 | 18 |
  Treatment related mortality | 1 | 0.5 |
  Death other causes | 1 | 0.5 |
  Unknown | 5 | 2.5 |
 Disease status at last visit | ||
  Alive in remission | 176 | 88 |
  Alive with disease | 4 | 2 |
  Alive unknown status | 1 | 0.5 |
  Lost to follow up | 6 | 3 |
  On treatment | 2 | 1 |
  Died of disease | 8 | 4 |
  Died of other causec | 3 | 1.5 |
High grade transformation | 11 | 5.5 |
HDC auto-SCT | 29 | 14.5 |